|
Generic Name : Infliximab
Pronunciation : in flix' i mab
Therapeutic Classification : Antirheumatics
ICD Code : Y45.4
Trade Name(s): International- Remicade. Why it is prescribed (Indications) : This medication is a monoclonal antibody, prescribed for autoimmune disorders, joint pain, Crohn's disease, inflammatory bowel disease, ankylosing spondylitis, psoriasis. It blocks the action of TNF-alpha, a substance in the body that causes inflammation. When it is not to be taken (Contraindications): Allergic to any components of the product, patients with moderate to severe heart failure should not receive more than 5 mg/kg.
Dosage & When it is to be taken : It is administered intravenously in a dose of 5 mg/kg on day 1, second week, sixth week, and then after every 6 weeks. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein. Warnings and Precautions : *Avoid vaccination while taking this medication. *Caution should be exercised in patients with history of hepatitis B. *It may develop an active infection while using this medication. Side Effects : Gastrointestinal- Stomach pain, nausea, loss of appetite and blood in stool. Heart- Chest pain and shortness of breath. Miscellaneous- Headache, runny nose, vaginal itching, flushing, rash, joint pain and seizures. *It may affect blood clots, avoid unusual bruising or bleeding. Storage Conditions : Store vials (powder for injection) in refrigerator (36° to 46°F). Do not freeze. |
![]() Comment & Contribute
![]()
![]() ![]() | ||




Ask an Expert